Simon Harris and Taoiseach Leo Varadkar meet to discuss Slaintecare

The transcript discusses the collaborative efforts with industry stakeholders, HPRA, and HSE to prepare for Brexit, focusing on medicine supply. It highlights the notification system for medicine shortages and advises against stockpiling to prevent supply chain disruptions. The transcript reassures that there are no current notifications of medicine shortages directly linked to Brexit.

What is the main focus of the collaborative efforts between stakeholders mentioned in the first section?

• Improving healthcare services

• Reducing healthcare costs

• Preparing for Brexit

• Developing new medicines

Why is it advised not to stockpile medications?

• It increases the cost of medicines

• It can lead to a shortage in the supply chain

• It is illegal to stockpile medicines

• It causes confusion among patients

What is the duration of medicine supply available in the country as mentioned in the second section?

• 12 to 14 weeks

• 10 to 12 weeks

• 6 to 8 weeks

• 4 to 6 weeks

What does the HPRA publish regarding medicine shortages?

• A list of new medicines

• A list of available medicines

• A list of medicine shortages

• A list of medicine prices

What reassurance is given about medicine supply post-Brexit?

• No medicines will be supplied

• There are no notifications of supply issues

• There will be a significant shortage

• All medicines will be stockpiled